685 related articles for article (PubMed ID: 28218725)
1. Treating Cancer by Targeting Telomeres and Telomerase.
Ivancich M; Schrank Z; Wojdyla L; Leviskas B; Kuckovic A; Sanjali A; Puri N
Antioxidants (Basel); 2017 Feb; 6(1):. PubMed ID: 28218725
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of Action of G-Quadruplex-Forming Oligonucleotide Homologous to the Telomere Overhang in Melanoma.
Chhabra G; Wojdyla L; Frakes M; Schrank Z; Leviskas B; Ivancich M; Vinay P; Ganapathy R; Ramirez BE; Puri N
J Invest Dermatol; 2018 Apr; 138(4):903-910. PubMed ID: 29203363
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of Telomere G-Quadruplexes Interferes with Human Herpesvirus 6A Chromosomal Integration.
Gilbert-Girard S; Gravel A; Artusi S; Richter SN; Wallaschek N; Kaufer BB; Flamand L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468887
[TBL] [Abstract][Full Text] [Related]
5. Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapy.
Crees Z; Girard J; Rios Z; Botting GM; Harrington K; Shearrow C; Wojdyla L; Stone AL; Uppada SB; Devito JT; Puri N
Curr Pharm Des; 2014; 20(41):6422-37. PubMed ID: 24975605
[TBL] [Abstract][Full Text] [Related]
6. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
[TBL] [Abstract][Full Text] [Related]
7. Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
Schrank Z; Khan N; Osude C; Singh S; Miller RJ; Merrick C; Mabel A; Kuckovic A; Puri N
Molecules; 2018 Sep; 23(9):. PubMed ID: 30189661
[TBL] [Abstract][Full Text] [Related]
8. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.
Jones KR; Elmore LW; Jackson-Cook C; Demasters G; Povirk LF; Holt SE; Gewirtz DA
Int J Radiat Biol; 2005 Jun; 81(6):445-58. PubMed ID: 16308915
[TBL] [Abstract][Full Text] [Related]
9. Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells.
Zhou G; Liu X; Li Y; Xu S; Ma C; Wu X; Cheng Y; Yu Z; Zhao G; Chen Y
Oncotarget; 2016 Mar; 7(12):14925-39. PubMed ID: 26908447
[TBL] [Abstract][Full Text] [Related]
10. Human telomerase is directly regulated by non-telomeric TRF2-G-quadruplex interaction.
Sharma S; Mukherjee AK; Roy SS; Bagri S; Lier S; Verma M; Sengupta A; Kumar M; Nesse G; Pandey DP; Chowdhury S
Cell Rep; 2021 May; 35(7):109154. PubMed ID: 34010660
[TBL] [Abstract][Full Text] [Related]
11. Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy.
Eckburg A; Dein J; Berei J; Schrank Z; Puri N
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825005
[TBL] [Abstract][Full Text] [Related]
12. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
13. Position-Dependent Effect of Guanine Base Damage and Mutations on Telomeric G-Quadruplex and Telomerase Extension.
Lee HT; Sanford S; Paul T; Choe J; Bose A; Opresko PL; Myong S
Biochemistry; 2020 Jul; 59(28):2627-2639. PubMed ID: 32578995
[TBL] [Abstract][Full Text] [Related]
14. Telomere inhibition and telomere disruption as processes for drug targeting.
Rezler EM; Bearss DJ; Hurley LH
Annu Rev Pharmacol Toxicol; 2003; 43():359-79. PubMed ID: 12540745
[TBL] [Abstract][Full Text] [Related]
15. G-Quadruplex DNA as a target for drug design.
Kerwin SM
Curr Pharm Des; 2000 Mar; 6(4):441-78. PubMed ID: 10788591
[TBL] [Abstract][Full Text] [Related]
16. Telomerase enzymatic component hTERT shortens long telomeres in human cells.
Zheng YL; Zhang F; Sun B; Du J; Sun C; Yuan J; Wang Y; Tao L; Kota K; Liu X; Schlegel R; Yang Q
Cell Cycle; 2014; 13(11):1765-76. PubMed ID: 24721976
[TBL] [Abstract][Full Text] [Related]
17. Platinum(II) phenanthroimidazole G-quadruplex ligand induces selective telomere shortening in A549 cancer cells.
Mancini J; Rousseau P; Castor KJ; Sleiman HF; Autexier C
Biochimie; 2016 Feb; 121():287-97. PubMed ID: 26724375
[TBL] [Abstract][Full Text] [Related]
18. Super-telomeres in transformed human fibroblasts.
Chiodi I; Belgiovine C; Zongaro S; Ricotti R; Horard B; Lossani A; Focher F; Gilson E; Giulotto E; Mondello C
Biochim Biophys Acta; 2013 Aug; 1833(8):1885-93. PubMed ID: 23570868
[TBL] [Abstract][Full Text] [Related]
19. Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target.
Pal J; Gold JS; Munshi NC; Shammas MA
Transl Res; 2013 Dec; 162(6):364-70. PubMed ID: 24090770
[TBL] [Abstract][Full Text] [Related]
20. Targeting telomerase and telomeres to enhance ionizing radiation effects in in vitro and in vivo cancer models.
Berardinelli F; Coluzzi E; Sgura A; Antoccia A
Mutat Res Rev Mutat Res; 2017 Jul; 773():204-219. PubMed ID: 28927529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
